A Population-Based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-Small Cell Lung Cancer Patients. Radiol Oncol 2018, 52 (2).